Literature DB >> 19222422

A haplotype in the inducible T-cell tyrosine kinase is a risk factor for seasonal allergic rhinitis.

M Benson1, R Mobini, F Barrenäs, C Halldén, A T Naluai, T Säll, L O Cardell.   

Abstract

BACKGROUND: Identification of disease-associated single nucleotide polymorphisms (SNPs) in seasonal allergic rhinitis (SAR) may be facilitated by focusing on genes in a disease-associated pathway.
OBJECTIVE: To search for SNPs in genes that belong to the T-cell receptor (TCR) pathway and that change in expression in allergen-challenged CD4+ cells from patients with SAR.
METHODS: CD4+ cells from patients with SAR were analysed with gene expression microarrays. Allele, genotype and haplotype frequencies were compared in 251 patients and 386 healthy controls.
RESULTS: Gene expression microarray analysis of allergen-challenged CD4+ cells from patients with SAR showed that 25 of 38 TCR pathway genes were differentially expressed. A total of 62 SNPs were analysed in eight of the 25 genes; ICOS, IL4, IL5, IL13, CSF2, CTLA4, the inducible T-cell tyrosine kinase (ITK) and CD3D. Significant chi-squared values were identified for several markers in the ITK kinase gene region. A total of five SNPs were nominally significant at the 5% level. Haplotype analysis of the five significant SNPs showed increased frequency of a haplotype that covered most of the coding part of ITK. The functional relevance of ITK was supported by analysis of an independent material, which showed increased expression of ITK in allergen-challenged CD4+ cells from patients, but not from controls.
CONCLUSION: Analysis of SNPs in TCR pathway genes revealed that a haplotype that covers a major part of the coding sequence of ITK is a risk factor for SAR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222422     DOI: 10.1111/j.1398-9995.2009.01991.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  5 in total

Review 1.  Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.

Authors:  Andrew Aw; Jennifer R Brown
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

2.  IL-2-inducible T-cell kinase (ITK) finds another (dance) partner...TFII-I.

Authors:  Avery August
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

Review 3.  ITK inhibitors in inflammation and immune-mediated disorders.

Authors:  Nisebita Sahu; Avery August
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

4.  Network properties of complex human disease genes identified through genome-wide association studies.

Authors:  Fredrik Barrenas; Sreenivas Chavali; Petter Holme; Reza Mobini; Mikael Benson
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

Review 5.  Targeting ITK signaling for T cell-mediated diseases.

Authors:  Samuel Weeks; Rebecca Harris; Mobin Karimi
Journal:  iScience       Date:  2021-07-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.